Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
Price Target
Average
138.97%
Revenue Forecast
Estimate
757.56%
EBIT
Estimate
--101.47%
Net Income
Estimate
27.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Inhibikase Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for IKT of $6.5 , with forecasts ranging from
a
low of
$5 to a high of $8 .
IKT Lowest Price Target
Wall Street Target
5 USD
83.82%
IKT Average Price Target
Wall Street Target
6.5 USD
138.97%
IKT Highest Price Target
Wall Street Target
8 USD
194.12%
REVENUE FORECAST
Revenue Forecast Chart IKT
EBIT FORECAST
EBIT Forecast Chart IKT
NET INCOME FORECAST
Net Income Chart IKT